|246.37||-2.82||-1.13%||Vol 2.26M||1Y Perf -1.73%|
|May 16th, 2022 16:03 DELAYED|
|- -||-0.07 -0.03%|
|Target Price||330.85||Analyst Rating||Strong Buy 1.50|
|Potential %||34.29||Finscreener Ranking||★★+ 48.43|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★ 50.61|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★ 59.48|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★★ 38.11|
|Price Range Ratio 52W %||12.63||Earnings Rating||Strong Buy|
|Market Cap||179.13B||Earnings Date||21st Apr 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||2.63|
|EPS Growth Next 5 Years %||8.70|
|Avg. Weekly Volume||2.99M|
|Avg. Monthly Volume||3.03M|
|Avg. Quarterly Volume||2.80M|
Danaher Corporation (NYSE: DHR) stock closed at 246.37 per share at the end of the most recent trading day (a -1.13% change compared to the prior day closing price) with a volume of 2.26M shares and market capitalization of 179.13B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 69000 people. Danaher Corporation CEO is Rainer M. Blair.
The one-year performance of Danaher Corporation stock is -1.73%, while year-to-date (YTD) performance is -25.12%. DHR stock has a five-year performance of 200.82%. Its 52-week range is between 233.708 and 333.96, which gives DHR stock a 52-week price range ratio of 12.63%
Danaher Corporation currently has a PE ratio of 28.80, a price-to-book (PB) ratio of 4.20, a price-to-sale (PS) ratio of 5.92, a price to cashflow ratio of 21.70, a PEG ratio of 2.32, a ROA of 8.14%, a ROC of 10.60% and a ROE of 16.10%. The company’s profit margin is 21.32%, its EBITDA margin is 33.30%, and its revenue ttm is $30.28 Billion , which makes it $41.65 revenue per share.
Of the last four earnings reports from Danaher Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.63 for the next earnings report. Danaher Corporation’s next earnings report date is -.
The consensus rating of Wall Street analysts for Danaher Corporation is Strong Buy (1.5), with a target price of $330.85, which is +34.29% compared to the current price. The earnings rating for Danaher Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Danaher Corporation has a dividend yield of 0.41% with a dividend per share of $1.00 and a payout ratio of 10.00%.
Danaher Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 11.47, ATR14 : 8.51, CCI20 : -53.73, Chaikin Money Flow : -0.16, MACD : -9.25, Money Flow Index : 32.23, ROC : -4.14, RSI : 40.64, STOCH (14,3) : 48.91, STOCH RSI : 0.85, UO : 48.47, Williams %R : -51.09), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Danaher Corporation in the last 12-months were: Angela S. Lalor (Option Excercise at a value of $2 469 480), Angela S. Lalor (Sold 37 513 shares of value $12 266 751 ), Brian W. Ellis (Option Excercise at a value of $2 374 200), Brian W. Ellis (Sold 41 365 shares of value $12 053 247 ), Daniel A. Raskas (Option Excercise at a value of $2 269 043), Daniel A. Raskas (Sold 49 188 shares of value $16 018 732 ), Elias A. Zerhouni (Sold 3 409 shares of value $1 119 594 ), Joakim Weidemanis (Option Excercise at a value of $1 328 974), Joakim Weidemanis (Sold 55 175 shares of value $15 769 032 ), Linda Hefner Filler (Option Excercise at a value of $518 849), Linda Hefner Filler (Sold 6 733 shares of value $2 068 255 ), Matthew R. McGrew (Option Excercise at a value of $567 860), Matthew R. McGrew (Sold 14 899 shares of value $4 454 501 ), Mitchell P. Rales (Sold 1 225 841 shares of value $377 905 905 ), Robert S. Lutz (Option Excercise at a value of $289 500), Robert S. Lutz (Sold 11 006 shares of value $3 097 029 ), Teri L. List-Stoll (Option Excercise at a value of $175 735), Teri L. List-Stoll (Sold 4 548 shares of value $1 160 194 )
Mon, 14 Feb 2022 18:03 GMT Danaher: Much Room for Growth When Looking Ahead- TipRanks. All rights reserved.
Sun, 02 Jan 2022 12:05 GMT Analysts Offer Insights on Healthcare Companies: Danaher (DHR) and Landos Biopharma (LABP)- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.